Literature DB >> 18198379

Dynamics of picornavirus RNA replication within infected cells.

Graham J Belsham1, Preben Normann1.   

Abstract

Replication of many picornaviruses is inhibited by low concentrations of guanidine. Guanidine-resistant mutants are readily isolated and the mutations map to the coding region for the 2C protein. Using in vitro replication assays it has been determined previously that guanidine blocks the initiation of negative-strand synthesis. We have now examined the dynamics of RNA replication, measured by quantitative RT-PCR, within cells infected with either swine vesicular disease virus (an enterovirus) or foot-and-mouth disease virus as regulated by the presence or absence of guanidine. Following the removal of guanidine from the infected cells, RNA replication occurs after a significant lag phase. This restoration of RNA synthesis requires de novo protein synthesis. Viral RNA can be maintained for at least 72 h within cells in the absence of apparent replication but guanidine-resistant virus can become predominant. Amino acid substitutions within the 2C protein that confer guanidine resistance to swine vesicular disease virus and foot-and-mouth disease virus have been identified. Even when RNA synthesis is well established, the addition of guanidine has a major impact on the level of RNA replication. Thus, the guanidine-sensitive step in RNA synthesis is important throughout the virus life cycle in cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18198379     DOI: 10.1099/vir.0.83385-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Viral kinetics of enterovirus 71 in human abdomyosarcoma cells.

Authors:  Jing Lu; Ya-Qing He; Li-Na Yi; Hong Zan; Hsiang-Fu Kung; Ming-Liang He
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

2.  Modification of the untranslated regions of human enterovirus 71 impairs growth in a cell-specific manner.

Authors:  Chee Choy Kok; Patchara Phuektes; Emily Bek; Peter C McMinn
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

3.  Deletion mutants of VPg reveal new cytopathology determinants in a picornavirus.

Authors:  Armando Arias; Celia Perales; Cristina Escarmís; Esteban Domingo
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

4.  Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture.

Authors:  Sara Sadeghipour; Emily J Bek; Peter C McMinn
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

5.  Rescue of foot-and-mouth disease viruses that are pathogenic for cattle from preserved viral RNA samples.

Authors:  Graham J Belsham; Syed M Jamal; Kirsten Tjørnehøj; Anette Bøtner
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

6.  Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with a coordinated ATP hydrolysis mechanism.

Authors:  Trevor R Sweeney; Valentina Cisnetto; Daniel Bose; Matthew Bailey; Jon R Wilson; Xiaodong Zhang; Graham J Belsham; Stephen Curry
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

Review 7.  Methods to detect infectious human enteric viruses in environmental water samples.

Authors:  Ibrahim Ahmed Hamza; Lars Jurzik; Klaus Überla; Michael Wilhelm
Journal:  Int J Hyg Environ Health       Date:  2011-09-15       Impact factor: 5.840

8.  Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment.

Authors:  Celia Perales; Rubén Agudo; Esteban Domingo
Journal:  PLoS One       Date:  2009-05-14       Impact factor: 3.240

9.  The Cellular Chaperone Heat Shock Protein 90 Is Required for Foot-and-Mouth Disease Virus Capsid Precursor Processing and Assembly of Capsid Pentamers.

Authors:  Joseph Newman; Amin S Asfor; Stephen Berryman; Terry Jackson; Stephen Curry; Tobias J Tuthill
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

10.  Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents.

Authors:  Su-Mi Kim; Jong-Hyeon Park; Kwang-Nyeong Lee; Se-Kyung Kim; Young-Joon Ko; Hyang-Sim Lee; In-Soo Cho
Journal:  Antiviral Res       Date:  2012-09-21       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.